2401 - 2410 of 8137 Results
Title
Year
-
OPENTitle: Association between cigarette smoking and Parkinson’s disease: a neuroimaging studyJournal Name: Therapeutic Advances in Neurological DisordersPublisher: SAGE PublicationsVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/17562864221092566Best OA location URL: https://doi.org/10.1177/17562864221092566Citation Count: 25
- Association of vitamin K with cognitive decline and neuropathology in community‐dwelling older persons2022OPENTitle: Association of vitamin K with cognitive decline and neuropathology in community‐dwelling older personsJournal Name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsPublisher: WileyVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/trc2.12255Best OA location URL: https://doi.org/10.1002/trc2.12255Citation Count: 36
- At a Glance: An Update on Neuroimaging and Retinal Imaging in Alzheimer’s Disease and Related Research2022OPENTitle: At a Glance: An Update on Neuroimaging and Retinal Imaging in Alzheimer’s Disease and Related ResearchJournal Name: The Journal of Prevention of Alzheimer's DiseasePublisher: Elsevier BVVol: 9Issue #: 1Start Page: 1End Page: 10Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.14283/jpad.2022.7Best OA location URL: https://link.springer.com/content/pdf/10.14283/jpad.2022.7.pdfCitation Count: 1
- c‐Abl Inhibitors as Disease‐Modifying Therapies for Parkinson's Disease: Gaps and Opportunities2022RESTRICTEDTitle: c‐Abl Inhibitors as Disease‐Modifying Therapies for Parkinson's Disease: Gaps and OpportunitiesJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 1Start Page: 3End Page: 5Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28907Citation Count: 3
- Cerebral topography of vesicular cholinergic transporter changes in neurologically intact adults: A [18F]FEOBV PET study2022OPENTitle: Cerebral topography of vesicular cholinergic transporter changes in neurologically intact adults: A [18F]FEOBV PET studyJournal Name: Aging BrainPublisher: Elsevier BVVol: 2Issue #:Start Page: 100039End Page: 100039Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbas.2022.100039Best OA location URL: https://doi.org/10.1016/j.nbas.2022.100039Citation Count: 26
-
RESTRICTEDTitle: Characterization of Axon Guidance Phenotypes in Wnt/PCP Mutant MiceJournal Name: Methods in Molecular BiologyPublisher: Springer USVol:Issue #:Start Page: 277End Page: 286Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/978-1-0716-2035-9_17Citation Count: 3
-
RESTRICTEDTitle: Clinical neurophysiology of Parkinson’s disease and parkinsonismJournal Name: Clinical Neurophysiology PracticePublisher: Elsevier BVVol: 7Issue #:Start Page: 201End Page: 227Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cnp.2022.06.002Best OA location URL: https://doi.org/10.1016/j.cnp.2022.06.002Citation Count: 33
- Concurrent validity of Zeno instrumented walkway and video-based gait features in adults with Parkinson’s disease2022OPENTitle: Concurrent validity of Zeno instrumented walkway and video-based gait features in adults with Parkinson’s diseaseJournal Name: IEEE Journal of Translational Engineering in Health and MedicinePublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 10Issue #:Start Page: 1End Page: 11Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1109/jtehm.2022.3180231Best OA location URL: https://ieeexplore.ieee.org/ielx7/6221039/6563131/09787410.pdfCitation Count: 22
- Considerations for clinical trial design and conduct in the evaluation of novel advanced therapeutics in neurodegenerative disease2022RESTRICTEDTitle: Considerations for clinical trial design and conduct in the evaluation of novel advanced therapeutics in neurodegenerative diseaseJournal Name: International Review of NeurobiologyPublisher: ElsevierVol:Issue #:Start Page: 235End Page: 279Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/bs.irn.2022.09.006Citation Count: 0
- Deep learning for Parkinson’s disease symptom detection and severity evaluation using accelerometer signal2022OPENTitle: Deep learning for Parkinson’s disease symptom detection and severity evaluation using accelerometer signalJournal Name: ESANN 2022 proceedingsPublisher: Ciaco - i6doc.comVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.14428/esann/2022.es2022-107Best OA location URL: https://doi.org/10.14428/esann/2022.es2022-107Citation Count: 0